Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Net Cash Flow (2016 - 2025)

Guided Therapeutics' Net Cash Flow history spans 15 years, with the latest figure at -$24000.0 for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 112.37% to -$24000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$323000.0, a 59.11% decrease, with the full-year FY2025 number at -$325000.0, down 60.1% from a year prior.
  • Net Cash Flow hit -$24000.0 in Q4 2025 for Guided Therapeutics, up from -$96000.0 in the prior quarter.
  • Over the last five years, Net Cash Flow for GTHP hit a ceiling of $2.2 million in Q3 2022 and a floor of -$627000.0 in Q3 2023.
  • Historically, Net Cash Flow has averaged -$5150.0 across 5 years, with a median of -$143000.0 in 2023.
  • Biggest five-year swings in Net Cash Flow: soared 690.03% in 2022 and later tumbled 680.49% in 2023.
  • Tracing GTHP's Net Cash Flow over 5 years: stood at $102000.0 in 2021, then crashed by 476.47% to -$384000.0 in 2022, then soared by 63.54% to -$140000.0 in 2023, then soared by 238.57% to $194000.0 in 2024, then plummeted by 112.37% to -$24000.0 in 2025.
  • Business Quant data shows Net Cash Flow for GTHP at -$24000.0 in Q4 2025, -$96000.0 in Q3 2025, and $70000.0 in Q2 2025.